ArticlePloS one2025
Immature Citrus unshiu fruit extracts inhibit adipogenesis in 3T3-L1 adipocytes via AMPK and MAPK signaling pathways.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Korea, immature citrus fruits have been extensively explored for their potential utility as functional bio-health materials owing to their various bioactive properties. However, the specific mechanisms by which they exert inhibitory effects on adipogenesis remain unclear. Therefore, this study aimed to examine the anti-obesity effects of 70% ethanol extracts of immature Citrus unshiu fruits and their solvent fractions (n-hexane, ethyl acetate, n-butanol, and water) on 3T3-L1 cells, as well as to explore the underlying molecular mechanisms. Additionally, this study was conducted to identify the bioactive components responsible for the anti-obesity effects. Among the fractions, the hexane fraction exhibited the most potent inhibitory effect on lipid accumulation in 3T3-L1 cells without inducing cytotoxicity. Notably, this effect was concentration-dependent. This fraction also inhibited adipogenesis during the differentiation of 3T3-L1 preadipocytes by downregulating the expression of CCAAT/enhancer-binding proteins (C/EBP), peroxisome proliferator-activated receptor-γ (PPARγ), sterol regulatory element-binding protein (SREBP), fatty acid synthase (FAS), and fatty acid binding protein 4 (FABP4). Moreover, the hexane fraction modulated the activity of AMP-activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPK), both of which play critical roles in lipid metabolism. Specifically, it induced AMPK activation while downregulating MAPK signaling. Phytochemical analysis identified phytol, hexatriacontane, tangeretin, and nobiletin as the main bioactive components responsible for the observed anti-obesity effects of ICE. Overall, our results revealed that ICE exhibited notable anti-obesity activity by targeting the AMPK and MAPK signaling pathways, highlighting its potential as a natural therapeutic agent for obesity management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.